CF
CVS icon

C.T. Fitzpatrick’s CVS Health CVS Stock Holding History

C.T. Fitzpatrick’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,751
Closed -$658K – 39
2021
Q1 		$658K Sell
8,751
-3,221,594
-100% -$235M ﹤0.01% 40
2020
Q4 		$221M Buy
3,230,345
+178,500
+6% +$11.6M 1.43% 21
2020
Q3 		$178M Sell
3,051,845
-1,332,165
-30% -$82.9M 1.39% 20
2020
Q2 		$285M Sell
4,384,010
-924,705
-17% -$58.2M 2.24% 19
2020
Q1 		$315M Sell
5,308,715
-1,373,177
-21% -$91.7M 3.26% 15
2019
Q4 		$496M Sell
6,681,892
-2,073,020
-24% -$146M 3.81% 13
2019
Q3 		$552M Sell
8,754,912
-171,719
-2% -$10.2M 4.67% 7
2019
Q2 		$486M Buy
8,926,631
+968,162
+12% +$52.1M 4.32% 8
2019
Q1 		$429M Buy
7,958,469
+2,881,953
+57% +$178M 3.7% 12
2018
Q4 		$333M Sell
5,076,516
-734,563
-13% -$54.8M 3.07% 16
2018
Q3 		$457M Sell
5,811,079
-3,711,665
-39% -$265M 3.34% 14
2018
Q2 		$613M Buy
9,522,744
+217,406
+2% +$14.3M 4.74% 5
2018
Q1 		$579M Buy
9,305,338
+465,460
+5% +$33.4M 4.66% 3
2017
Q4 		$641M Buy
8,839,878
+103,776
+1% +$7.54M 5.25% 4
2017
Q3 		$710M Buy
8,736,102
+1,046,719
+14% +$82.8M 6.08% 3
2017
Q2 		$619M Buy
7,689,383
+102,834
+1% +$8.12M 5.51% 2
2017
Q1 		$596M Buy
7,586,549
+2,252,242
+42% +$180M 5.14% 3
2016
Q4 		$421M Buy
+5,334,307
New +$432M 3.75% 8
2016
Q1 		– Sell
-2,150
Closed -$210K – 62
2015
Q4 		$210K Buy
+2,150
New +$211K ﹤0.01% 61
2014
Q3 		– Sell
-475
Closed -$36K – 85
2014
Q2 		$36K Buy
+475
New +$35.9K ﹤0.01% 84

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

C.T. Fitzpatrick's CVS Position: Q2 2021 in Review

C.T. Fitzpatrick sold out of CVS Health (CVS) in Q2 2021, closing a stake of 8,751 shares — an estimated $658K sold.

C.T. Fitzpatrick first reported a position in CVS in Q2 2014 and held it in 20 quarters. The position peaked at $710M in Q3 2017. 2,065 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

  • C.T. Fitzpatrick reported no remaining CVS Health position as of Q2 2021 after selling out during the quarter.
  • C.T. Fitzpatrick sold 8,751 CVS Health shares in Q2 2021, an estimated $658K.
  • C.T. Fitzpatrick first reported a position in CVS Health in Q2 2014 and held it in 20 quarters.
  • C.T. Fitzpatrick's CVS Health position peaked at $710M in Q3 2017.
  • 2,065 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on Vulcan Value Partners's 13F filing for Q2 2021, filed 16 Aug 2021.